News & Media
Tuesday, May 5, 2020
Sunnybrook researchers awarded $1.84 million for further study of synthetic cannabinoid in Alzheimer’s disease
Sunnybrook researchers awarded $1.84 million for further study of synthetic cannabinoid in Alzheimer’s disease
![](../image.asp?h=537&w=634&mode=crop&i=1/_research/news/2020/chan-ak-ian-brown-photography-1.jpg)
Can an existing HIV medication slow the spread of COVID-19? Team of Toronto researchers launches clinical trial to find out
![](../image.asp?h=537&w=634&mode=crop&i=1/_research/news/2020/lovit-picture.jpg)
Can intravenous vitamin C help critically ill COVID-19 patients? Sunnybrook's LOVIT trial aims to find out
Wednesday, April 15, 2020
Participate in COVID-19 research at Sunnybrook
Participate in COVID-19 research at Sunnybrook
Thursday, April 9, 2020
Canadian hospitals trialing new treatment options for COVID-19 patients
Canadian hospitals trialing new treatment options for COVID-19 patients